Starting January 1, 2025, many Americans with private health insurance will have expanded access to blood pressure monitoring equipment at no additional cost. Under new federal guidance, health plans must cover blood pressure monitors for pregnant individuals as preventive care, addressing rising rates of hypertensive disorders during pregnancy.
Expanded Coverage for Maternal Health
The U.S. Department of Health and Human Services (HHS), alongside the Department of Labor and the Department of the Treasury, issued updated guidance clarifying the preventive services mandate under the Affordable Care Act (ACA). Beginning with plan years that start on or after January 1, 2025, insurers are required to cover blood pressure monitors without cost-sharing—meaning no copays, coinsurance, or deductibles—for individuals who are pregnant or postpartum.
This policy change aims to facilitate the early detection of preeclampsia and other forms of gestational hypertension. According to the Centers for Disease Control and Prevention (CDC), hypertensive disorders affect approximately 1 in 7 hospital deliveries in the United States. Early identification through home monitoring allows clinicians to intervene sooner, which can reduce the risk of complications such as stroke, organ damage, and preterm birth.
Requirements for Health Plan Compliance
The federal requirement applies to most private health insurance plans, including those offered through the Health Insurance Marketplace and employer-sponsored coverage. Under the ACA’s preventive services provisions, plans must cover items or services with an "A" or "B" rating from the U.S. Preventive Services Task Force (USPSTF) without cost-sharing.
While the specific implementation details may vary by insurer, the guidance mandates that:
- Coverage is mandatory: Plans cannot charge the patient for the cost of a home blood pressure monitor when prescribed by a healthcare provider.
- Clinical Necessity: The equipment must be provided to individuals during pregnancy and for the duration of the postpartum period, as defined by the updated clinical guidelines.
- Preventive Designation: Because the monitor is classified as a preventive service, it is exempt from standard out-of-pocket expenses that might otherwise apply to durable medical equipment.
Why Home Monitoring Matters
Clinical research supports the use of home blood pressure monitoring as a standard of care for high-risk pregnancies. Monitoring blood pressure outside of a clinical setting provides a more accurate picture of a patient’s health, as "white coat hypertension"—where blood pressure readings are elevated due to stress in a doctor’s office—can lead to misdiagnosis.
By removing the financial barrier to purchasing a reliable, clinically validated monitor, federal regulators intend to standardize care across different socioeconomic groups. Patients should contact their insurance provider or healthcare team to confirm the specific process for obtaining a monitor, as some plans may require a formal prescription from an obstetrician or primary care physician to verify the medical necessity of the equipment.
Summary of Benefits
- Cost: $0 out-of-pocket for covered individuals.
- Eligibility: Individuals who are pregnant or in the postpartum period.
- Timeline: Effective for plan years beginning on or after January 1, 2025.
- Goal: Improve maternal health outcomes by enabling consistent, home-based blood pressure tracking.
This update represents a shift toward prioritizing maternal health as a core component of preventive medicine. Patients are encouraged to discuss the use of home monitoring with their healthcare providers to establish a schedule for tracking and reporting their readings during their pregnancy journey.